Search Results - "Rourke, Colm O"
-
1
Loss of Actin-Binding LIM protein (ABLIM) plays a potential role in migratory cholangiocyte transformation
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
2
-
3
SAT-226 - KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
4
Scavenger receptor MARCO is associated with an immunosuppressive microenvironment and tumor progression in intrahepatic cholangiocarcinoma
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
5
KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
6
PS-044-Identification of a pan-gamma-secretase inhibitor response signature for notch-driven cholangiocarcinoma
Published in Journal of hepatology (01-04-2019)Get full text
Journal Article -
7
FRI-472-YI Mitochondrial metabolism is disrupted by ciprofloxacin preventing cholangiocarcinoma cell proliferation
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article -
8
THU-251 - CD73high biliary tract cancer (BTC): a molecularly-defined subtype with distinct clinical implications
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
9
Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
10
SAT-223 - Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
11
SAT-230 - Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
12
CD73high biliary tract cancer (BTC): a molecularly-defined subtype with distinct clinical implications
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
13
Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
14
Circulating vesicles hold etiology-related protein biomarkers of cholangiocarcinoma risk, early diagnosis and prognosis mirroring tumour cells
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
15
Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
16
SAT-238 - Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
17
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Published in Journal of hepatology (01-07-2022)“…Cholangiocarcinoma (CCA) comprises a heterogeneous group of malignant tumors associated with dismal prognosis. Alterations in post-translational modifications…”
Get full text
Journal Article -
18
-
19
TREM2 protects the liver against hepatocellular carcinoma through multifactorial protective mechanisms
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
20
SAT054 - mIR-21 is increased in patients with NASH-associated HCC and contributes to hepatocarcinogenesis in mice with NAFLD
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article